Literature DB >> 11200363

Plasma cytokine response in mice with bacterial infection.

M Abram1, D Vu ković, B Wraber, M Dorić.   

Abstract

BACKGROUND: Exposure to microorganisms elicts the production of cytokines. These soluble factors enhance several innate immune functions and regulate the ensuing specific immune response aimed at limiting the spread of infection. AIM: This study was undertaken to quantify the plasma levels of pro-inflammatory cytokines during the course of primary Listeria monocytogenes and Campylobacter jejuni infection. Using an in vivo infection the relationship between endogenous cytokines and the bacterial number in the liver of infected animals was examined.
METHODS: C57BL/6 mice were infected by the intraperitoneal route. At different time points we determined the number of colony-forming units of bacteria in the liver of infected animals and paralled these with the plasma levels of interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) measured by enzyme immunoassays.
RESULTS: L. monocytogenes infection lasted 10-11 days. IFN-gamma production occurred in the early phase but was more pronounced after day 4, following the appearance of specific immunity. The duration of experimental campylobacteriosis was 15 days. Early IFN-gamma production was not significant but a progressive rise of this cytokine in plasma was seen during the second week post infection. Mice produced measurable amounts of plasma TNF-alpha immediately after being given viable L. monocytogenes, peaking on day 2-3 when the greatest number of bacteria was present in the examined organs. During C. jejuni infection plasma TNF-alpha was produced in a similar manner, but the highest concentrations were found a few days later than in listeriosis, in correlation with the different course of campylobacteriosis. The quantity of IL-6 increased and decreased in concordance with clearance of L monocytogenes and the clinical status of the animals. C. jejuni did not promote the induction of this cytokine. This is to some extent an unusual finding. With respect to the role of IL-6 in Th2 responses and antibody production, the appearance of this cytokine in campylobacteriosis was more expected. DISCUSSION: During systemic bacterial infection, a network of pro-inflammatory cytokines is activated and blood levels of these cytokines are elevated, albeit inconsistently, with large individual variations and depending on microbial characteristics and structure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11200363      PMCID: PMC1781766          DOI: 10.1080/09629350020025746

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  29 in total

1.  Campylobacter jejuni infection occurring during pregnancy.

Authors:  A E Simor; S Ferro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

2.  Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis.

Authors:  A J Simpson; M D Smith; G J Weverling; Y Suputtamongkol; B J Angus; W Chaowagul; N J White; S J van Deventer; J M Prins
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

3.  Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections.

Authors:  A Nakane; T Minagawa; M Kohanawa; Y Chen; H Sato; M Moriyama; N Tsuruoka
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

4.  Evidence that tumor necrosis factor has an important role in antibacterial resistance.

Authors:  E A Havell
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

5.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

6.  Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.

Authors:  M Belosevic; D S Finbloom; P H Van Der Meide; M V Slayter; C A Nacy
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

7.  Susceptibility of Campylobacter jejuni to strain-specific bactericidal activity in sera of infected patients.

Authors:  R A Pennie; R D Pearson; L J Barrett; H Lior; R L Guerrant
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

8.  Susceptibility of Campylobacter isolates to the bactericidal activity of human serum.

Authors:  M J Blaser; P F Smith; P F Kohler
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

9.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.

Authors:  J C Mathison; E Wolfson; R J Ulevitch
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

10.  Cellular resistance to infection.

Authors:  G B MACKANESS
Journal:  J Exp Med       Date:  1962-09-01       Impact factor: 14.307

View more
  9 in total

1.  Circulating cell-derived microparticles in Crohn's disease.

Authors:  Patrick Chamouard; Dominique Desprez; Bénédicte Hugel; Corinne Kunzelmann; Carole Gidon-Jeangirard; Michel Lessard; René Baumann; Jean-Marie Freyssinet; Lélia Grunebaum
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

2.  Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.

Authors:  Nadia Al-Banna; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

3.  Dendritic cells from C57BL/6 mice undergo activation and induce Th1-effector cell responses against Campylobacter jejuni.

Authors:  Vijay A K Rathinam; Kathleen A Hoag; Linda S Mansfield
Journal:  Microbes Infect       Date:  2008-08-05       Impact factor: 2.700

4.  Norepinephrine increases the pathogenic potential of Campylobacter jejuni.

Authors:  T A Cogan; A O Thomas; L E N Rees; A H Taylor; M A Jepson; P H Williams; J Ketley; T J Humphrey
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

5.  Systemic and local CC chemokines production in a murine model of Listeria monocytogenes infection.

Authors:  Marina Bubonja; Branka Wraber; Gordana Brumini; Ivana Gobin; Danijela Veljkovic; Maja Abram
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

6.  Psl Produced by Mucoid Pseudomonas aeruginosa Contributes to the Establishment of Biofilms and Immune Evasion.

Authors:  Christopher J Jones; Daniel J Wozniak
Journal:  MBio       Date:  2017-06-20       Impact factor: 7.867

7.  Sialoadhesin promotes rapid proinflammatory and type I IFN responses to a sialylated pathogen, Campylobacter jejuni.

Authors:  Mariliis Klaas; Cornelia Oetke; Leanne E Lewis; Lars P Erwig; Astrid P Heikema; Alistair Easton; Hugh J Willison; Paul R Crocker
Journal:  J Immunol       Date:  2012-07-30       Impact factor: 5.422

8.  Induction of cytokines in different organs after intranasal inoculation of Campylobacter jejuni in mice.

Authors:  Nadia A Al-Banna; Raj Raghupathy; M John Albert
Journal:  Gut Pathog       Date:  2012-12-17       Impact factor: 4.181

9.  Salivary levels of tumor necrosis factor-alpha in oral lichen planus.

Authors:  Sonja Pezelj-Ribaric; Ivana Brekalo Prso; Maja Abram; Irena Glazar; Gordana Brumini; Marica Simunovic-Soskic
Journal:  Mediators Inflamm       Date:  2004-04       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.